Literature DB >> 34132806

The Conundrum of Kappa and why some Musculoskeletal Tests Appear Unreliable despite High Agreement: A Comparison of Cohen Kappa and Gwet's AC to Assess Observer Agreement when Using Nominal and Ordinal Data.

Michael T Cibulka, Michael J Strube.   

Abstract

In clinical practice, physical therapists often use different kinds of tests and measures in the assessment of their patients. For therapists to have confidence when using their tests and measures, an important attribute is having intratester and intertester reliability. Studies that assess reliability are cases of observer agreement. Many studies have been performed assessing observer agreement in the physical therapy literature. The most often used method to assess observer agreement studies that use using nominal or ordinal data is the statistical method suggested by Cohen and the corresponding reliability coefficient, Cohen kappa. Recently, Cohen kappa has undergone scrutiny because of what is called kappa paradox, which occurs when observer agreement is high but the resulting kappa value is low. Another paradox also occurs when asymmetries exist between raters on their disagreements, resulting in a higher kappa value. In the physical therapy literature, there are numerous examples of this problem, which can often lead to misunderstanding the meaning of the data. This Perspective examines how and why these problems occur and suggests an alternative method for assessing observer agreement.
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Physical Therapy Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Kappa; Observer Agreement; Reliability

Year:  2021        PMID: 34132806     DOI: 10.1093/ptj/pzab150

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  1 in total

1.  Effect of application time of 38% silver diamine fluoride solution on arresting early childhood caries in preschool children: a randomised double-blinded controlled trial protocol.

Authors:  Iliana Gehui Yan; Faith Miaomiao Zheng; Sherry Shiqian Gao; Duangporn Duangthip; Edward Chin Man Lo; Chun Hung Chu
Journal:  Trials       Date:  2022-03-15       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.